UHRF1 promotes androgen receptor-regulated CDC6 transcription and anti-androgen receptor drug resistance in prostate cancer through KDM4C-Mediated chromatin modifications
Authors:
- 1 November 2021
- journal article
- research article
- Published by Elsevier in Cancer Letters
- Vol. 520, 172-183
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81572542)
- National Natural Science Foundation of China (81874096)
This publication has 29 references indexed in Scilit:
- Inhibiting UHRF1 expression enhances radiosensitivity in human esophageal squamous cell carcinomaMolecular Biology Reports, 2013
- The emerging role of histone lysine demethylases in prostate cancerMolecular Cancer, 2012
- UHRF1 confers radioresistance to human breast cancer cellsInternational Journal of Radiation Biology, 2010
- A novel androgen receptor-binding element modulates Cdc6 transcription in prostate cancer cells during cell-cycle progressionNucleic Acids Research, 2009
- Androgen deprivation therapy: progress in understanding mechanisms of resistance and optimizing androgen depletionNature Reviews Endocrinology, 2009
- The SRA domain of UHRF1 flips 5-methylcytosine out of the DNA helixNature, 2008
- Activity of Androgen Receptor Antagonist Bicalutamide in Prostate Cancer Cells Is Independent of NCoR and SMRT CorepressorsCancer Research, 2007
- Cooperative demethylation by JMJD2C and LSD1 promotes androgen receptor-dependent gene expressionNature Cell Biology, 2007
- Oncogene-induced senescence is part of the tumorigenesis barrier imposed by DNA damage checkpointsNature, 2006
- Androgen receptor expression in androgen‐independent prostate cancer cell linesThe Prostate, 2001